国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2015年
4期
656-658
,共3页
刘修铎%史春%应坚%徐惠娣%张玮
劉脩鐸%史春%應堅%徐惠娣%張瑋
류수탁%사춘%응견%서혜제%장위
激光%虹膜成形术%青光眼%成像
激光%虹膜成形術%青光眼%成像
격광%홍막성형술%청광안%성상
laser%iridoplasty%glaucoma%tomography
目的：观察 Nd：YAG532激光虹膜周边成形术( Laser peripheral iridoplasty,LPIP)治疗早期慢性闭角型青光眼效果与安全性。<br> 方法：2011-09/2012-10内诊断为早期慢性闭角型青光眼患者36例65眼,行LPIP。术前术后观察眼压、前房角、视力、视野、眼底、并发症等情况。随访12~24(平均18.2±6.7)mo。<br> 结果：术前眼压23.8±5.6mmHg,LPIP术后1wk；术后1,3,6,12mo眼压分别为18.7±3.8,17.9±3.2,17.6±3.5,18.4±3.7,18.6±3.7mmHg,与术前比较差异全部具有统计学意义( P<0.05)。最末次随访眼压为18.6±7.8mmHg,与术前比较平均下降6.5±3.1mmHg,差异具有统计学意义( t=5.32, P<0.05)。术后1wk；术后1,3,6mo相比术前的前房角角度( TIA500)与500μm前房角开放距离( AOD500)增大有非常显著差异( P<0.05),术后1 a与末次相比术前TIA500与 AOD500无统计学意义( P>0.05)。术后随访时间内视力无变化,杯盘比无增大,视野损害无进展。<br> 结论：激光虹膜周边成形术治疗早期慢性闭角型青光眼安全,短期内有效,中长期效果有回退,可以重复治疗。
目的：觀察 Nd：YAG532激光虹膜週邊成形術( Laser peripheral iridoplasty,LPIP)治療早期慢性閉角型青光眼效果與安全性。<br> 方法：2011-09/2012-10內診斷為早期慢性閉角型青光眼患者36例65眼,行LPIP。術前術後觀察眼壓、前房角、視力、視野、眼底、併髮癥等情況。隨訪12~24(平均18.2±6.7)mo。<br> 結果：術前眼壓23.8±5.6mmHg,LPIP術後1wk；術後1,3,6,12mo眼壓分彆為18.7±3.8,17.9±3.2,17.6±3.5,18.4±3.7,18.6±3.7mmHg,與術前比較差異全部具有統計學意義( P<0.05)。最末次隨訪眼壓為18.6±7.8mmHg,與術前比較平均下降6.5±3.1mmHg,差異具有統計學意義( t=5.32, P<0.05)。術後1wk；術後1,3,6mo相比術前的前房角角度( TIA500)與500μm前房角開放距離( AOD500)增大有非常顯著差異( P<0.05),術後1 a與末次相比術前TIA500與 AOD500無統計學意義( P>0.05)。術後隨訪時間內視力無變化,杯盤比無增大,視野損害無進展。<br> 結論：激光虹膜週邊成形術治療早期慢性閉角型青光眼安全,短期內有效,中長期效果有迴退,可以重複治療。
목적：관찰 Nd：YAG532격광홍막주변성형술( Laser peripheral iridoplasty,LPIP)치료조기만성폐각형청광안효과여안전성。<br> 방법：2011-09/2012-10내진단위조기만성폐각형청광안환자36례65안,행LPIP。술전술후관찰안압、전방각、시력、시야、안저、병발증등정황。수방12~24(평균18.2±6.7)mo。<br> 결과：술전안압23.8±5.6mmHg,LPIP술후1wk；술후1,3,6,12mo안압분별위18.7±3.8,17.9±3.2,17.6±3.5,18.4±3.7,18.6±3.7mmHg,여술전비교차이전부구유통계학의의( P<0.05)。최말차수방안압위18.6±7.8mmHg,여술전비교평균하강6.5±3.1mmHg,차이구유통계학의의( t=5.32, P<0.05)。술후1wk；술후1,3,6mo상비술전적전방각각도( TIA500)여500μm전방각개방거리( AOD500)증대유비상현저차이( P<0.05),술후1 a여말차상비술전TIA500여 AOD500무통계학의의( P>0.05)。술후수방시간내시력무변화,배반비무증대,시야손해무진전。<br> 결론：격광홍막주변성형술치료조기만성폐각형청광안안전,단기내유효,중장기효과유회퇴,가이중복치료。
AIM: To evaluate the safety of the laser peripheral iridoplasty ( LPIP ) for the early-stage chronic primary angle-closure glaucoma ( ECPACG) . <br> METHODS:Sixty-five eyes of 36 patients with ECPACG received LPIP. At preoperative and postoperative, patients were examined with intraocular pressure ( IOP ) , anterior chamber, optical coherence tomography ( OCT) , visual acuity, visual field, fundus and complications. The mean follow-up was 18. 2±6. 7mo (ranged 12~24mo). <br> RESULTS: The preoperative average IOP were 23. 8±5.6mmHg, postoperative 1wk, 1, 3, 6, 12mo and in the last follow-up time the average IOP were 18. 7±3. 8, 17. 9±3. 2, 17. 6±3. 5, 18. 4±3. 7, 18. 6±3. 7, and 18. 6±7. 8mmHg. There was statistical difference comparing with preoperative (P<0. 05, decreasing average 6. 5±3. 1mmHg compared with the preoperative, the difference was statistically significant (t=5. 32, P<0. 05). Postoperative 1wk, 1, 3, 6mo, the trabecular-iris angle ( TIA500 ) and the angle opening distance at 500μm ( AOD500 ) had the statistical difference comparing with preoperative ( P <0.05). At Postoperative 1a and the last follow-up time, the TIA500 and AOD500 did not have statistical difference comparing with preoperative (P>0. 05). The postoperative visual acuity, visual field, fundus had not changed. There were no complications found. <br> CONCLUSION:LPIP is safe, and has the short time effect in the treatment of ECPACG. With elapse of time, the effect of LPIP is weakened. We can repeat the treatment.
